OPENING OF BANKRUPTCY

OXYPOINT

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
-624 k €
-3.2% YoY
Revenue
354,8 k €
+59.5% YoY
Equity
-747,1 k €
-506.9% YoY
Workforce
4,3 ETP
+30.3% YoY

Company — Opening of bankruptcy.

What does OXYPOINT do?

OXYPOINT is a Public limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Niel. It employs on average 4,3 ETP workers (FTE).

Legal situation
● Opening of bankruptcy
BCE/KBO no. / VAT
BE 0832.604.943
Incorporation
06/01/2011
Legal form
Public limited company
Registered office
Galileilaan 15
2845 Niel · FlandreSee on map
Contributed capital
1 325 472,92 €
Latest accounts
31/12/2024
Average workforce
4,3 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods72109Research and experimental development on natural sciences and engineering72190Other research and experimental development on natural sciences and engineering77225Rental of video tapes and disks77295Rental and leasing of other personal and household goods
Joint committees (1)
  • 200
Contacts
2 public details availableLog in to view
Signals
Healthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2024202320222021202020192018201720162015201420132012
Income statement
Revenue354,8 k €222,5 k €144,7 k €302,2 k €–––––––241,2 k €135,6 k €
EBITDA-377,2 k €-373,3 k €-633,3 k €-348,3 k €-222,8 k €-850,7 k €-790 k €-48,6 k €-8,4 k €-23,6 k €-20,5 k €13,5 k €68,8 k €
Operating result-566 k €-567,8 k €-823,3 k €-514,2 k €-328 k €-923,1 k €-805,7 k €-56,8 k €-16,1 k €-30,3 k €-27,6 k €7,8 k €60,9 k €
Net result-624 k €-604,8 k €-846,7 k €-515,9 k €-329,1 k €-928,5 k €-809,7 k €-60,3 k €-22,4 k €-29,5 k €-25,5 k €6,2 k €52,6 k €
Balance sheet
Equity-747,1 k €-123,1 k €481,7 k €1,3 M €1,8 M €1,3 M €1,6 M €41,7 k €102,1 k €124,4 k €153,9 k €179,4 k €72,7 k €
Total assets1,4 M €1,6 M €1,8 M €1,8 M €2,4 M €1,5 M €1,8 M €102,7 k €161,7 k €145,7 k €181,3 k €183,5 k €115,8 k €
Cash75,9 k €128,1 k €361,6 k €330,5 k €1,2 M €886,6 k €1,5 M €7 k €11,7 k €59,3 k €63,4 k €100,9 k €101,2 k €
Debts1,7 M €1,2 M €966,6 k €78,4 k €118,7 k €188 k €187,5 k €61 k €59,7 k €21,2 k €27,4 k €4,2 k €43,2 k €
Other
Workforce4,3 ETP3,3 ETP3,3 ETP2,4 ETP3,2 ETP5,7 ETP3,1 ETP–1,8 ETP1,0 ETP1,0 ETP1,0 ETP–
Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active · 15 ended

Active mandates

GEO-PHARM

Director · since 13 décembre 2024 · until 02 juin 2025 · 0667.520.049

Represented by Thiéry Damien

Active
Startegica

Director · since 03 juin 2022 · until 01 juin 2027 · 0834.987.381

Represented by Guy Lefever

Active
P&L Projects

Director · since 21 janvier 2022 · until 01 juin 2027 · 0652.876.118

Represented by FRANK PIETERS

Active
COFIMA

Director · since 25 mai 2021 · until 28 juin 2024

Represented by LUC HANSEN

Active
Innovamus

Director · since 23 mars 2018 · until 13 décembre 2024 · 0501.500.193

Represented by PHILIP HENDRICKX

Active

Ended mandates

COFIMA

Director · since 25 mai 2021 · until 03 juin 2024

Represented by LUC HANSEN

Ended
Kenneth Wils

Director · since 30 mars 2021 · until 23 mars 2024

Ended
Dirk Borgonjon

Director · since 26 décembre 2020 · until 24 octobre 2025

Ended
DIRK BORGONJON

Director · since 26 octobre 2020 · until 29 avril 2022

Ended
At this address

Other companies at this address

CompanyCBE no.
4VISO● Active
1027.105.086
ADM● Active
0463.498.167
BMCDENIS● Active
0834.200.394
BRIGHTSPEC● Active
0846.102.393
CAST4ALL● Active
0469.659.053
CIRCLAIR● Active
1017.358.665
CosProf Studio● Active
1011.646.553
EUROPEAN RESPIRATORY CLUSTER ANTWERP● Active
0692.724.114
FiriX Therapeutics● Active
1024.780.848
GRAND MEDICAL (EUROPE)● Active
0766.800.440
Hemplab Institute● Active
0649.743.810
KARDECO● Active
0427.600.348
Leveraging Affordable Solutions for Advanced Therapies● Active
0732.572.407
MOBILAR● Active
0779.489.327
NSX● Active
0840.966.838
ORYX GROUP● Bankrupt
0835.298.771
ORYX IT SERVICES● Bankrupt
0835.842.565
SIMMOCON● Active
0786.692.269
Sodecon● Active
0678.753.243
UBIS● Active
0546.545.708
Annual accounts

Full financial information

202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/07/202523/07/202412/07/202323/05/202201/07/202103/12/2020
General meeting26/06/202528/06/202419/06/202302/05/202201/06/202101/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

14 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202426/06/202515/07/2025DutchPDF
Abridged model31/12/202328/06/202423/07/2024DutchPDF
Abridged model31/12/202219/06/202312/07/2023DutchPDF
Abridged model31/12/202102/05/202223/05/2022DutchPDF
Abridged model31/12/202001/06/202101/07/2021DutchPDF
Abridged modelCorrection31/12/201901/06/202003/12/2020DutchPDF
Abridged model31/12/201901/06/202022/06/2020DutchPDF
Abridged model31/12/201825/04/201913/05/2019DutchPDF
Micro model30/09/201726/01/201828/03/2018DutchPDF
Abridged model30/09/201606/03/201729/03/2017DutchPDF
Abridged model30/09/201507/03/201621/03/2016DutchPDF
Abridged model30/09/201401/04/201501/04/2015DutchPDF
Abridged model30/09/201313/03/201427/03/2014DutchPDF
Abridged model30/09/201204/03/201327/03/2013DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active · 15 ended

Active mandates

GEO-PHARM

Director · since 13 décembre 2024 · until 02 juin 2025 · 0667.520.049

Represented by Thiéry Damien

Active
Startegica

Director · since 03 juin 2022 · until 01 juin 2027 · 0834.987.381

Represented by Guy Lefever

Active
P&L Projects

Director · since 21 janvier 2022 · until 01 juin 2027 · 0652.876.118

Represented by FRANK PIETERS

Active
COFIMA

Director · since 25 mai 2021 · until 28 juin 2024

Represented by LUC HANSEN

Active
Innovamus

Director · since 23 mars 2018 · until 13 décembre 2024 · 0501.500.193

Represented by PHILIP HENDRICKX

Active

Ended mandates

COFIMA

Director · since 25 mai 2021 · until 03 juin 2024

Represented by LUC HANSEN

Ended
Kenneth Wils

Director · since 30 mars 2021 · until 23 mars 2024

Ended
Dirk Borgonjon

Director · since 26 décembre 2020 · until 24 octobre 2025

Ended
DIRK BORGONJON

Director · since 26 octobre 2020 · until 29 avril 2022

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates10/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office08/02/2023
    MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates11/05/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates07/02/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/06/2021
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/04/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/04/2020
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other24/12/2019
    DIVERSEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-624 k €↓
  2. 2023
    Annual accounts 2023-604,8 k €↑
  3. 2022
    Annual accounts 2022-846,7 k €↓
  4. 2021
    Annual accounts 2021-515,9 k €↓
  5. 2020
    Annual accounts 2020-329,1 k €↑
  6. 2019
    Annual accounts 2019-928,5 k €↓
  7. 2018
    Annual accounts 2018-809,7 k €↓
  8. 2017
    Annual accounts 2017-60,3 k €↓
  9. 2016
    Annual accounts 2016-22,4 k €↑
  10. 2015
    Annual accounts 2015-29,5 k €↓
  11. 2014
    Annual accounts 2014-25,5 k €↓
  12. 2013
    Annual accounts 20136,2 k €↓
  13. 2012
    Annual accounts 201252,6 k €
  14. 06/01/2011
    IncorporationPublic limited company